Emory University

TFF Pharmaceuticals CEO Dr. Harlan Weisman [Photo TFF, Background DI Studio]

Fort Worth’s TFF Pharmaceuticals Partners to Develop Dry Powder-Inhaled mRNA Treatment for Flu and COVID

by David Seeley | Sep 13, 2024

Respiratory illnesses like influenza and COVID can change rapidly, requiring the nimble development and delivery of antiviral drugs to combat them. TFF is now partnering with Atlanta's Emory University and the Biomedical Advanced Research and Development Authority (BARDA) to test the feasibility of converting an Emory-developed mRNA antiviral into a dry powder formulation that needs no cold-chain storage.

MORE►

AI Can Detect Early Signs of Alzheimer’s in How People Speak, New Study Shows

by David Seeley | Apr 17, 2023

Subtle changes in the way people speak could help doctors diagnose cognitive impairment and Alzheimer’s disease—even before symptoms begin to show. That's according to a new study led UT Southwestern researcher Ihab Hajjar, M.D., working with a research team at Emory University in Atlanta. After being given standard cognitive assessments, 206 participants were asked to talk about an art work. Here's what happened next.

MORE►

UT Southwestern Researchers Secure $18 Million in Funding to Improve Postpartum Health Outcomes

by Dallas Innovates | Staff Report | Mar 28, 2023

UT Southwestern says the funding award is a significant step towards improving postpartum health outcomes for low-income women of color. The study aims to determine the best way to use technology to improve access to maternal health care and decrease complications after birth.

MORE►